Showing results (391-400 of 603) with videos related to
Sort By:
Pageof 61
American Journal of Hematology|April 11, 2025
The Impact of Melphalan Conditioning and CD34 + Cell Dose and Schedule on Post-Transplant Outcomes in AL AmyloidosisEli Muchtar, Vaishali Sanchorawala, Hamza Hassan, et al.Clinical Lymphoma, Myeloma & Leukemia|June 18, 2026
Ixazomib, Cyclophosphamide, and Dexamethasone (ICd), With or Without Daratumumab in Relapsed Multiple MyelomaShaji Kumar, Betsy Knopf, Erik Asmus, et al.American Journal of Hematology|March 11, 2015
Soluble suppression of tumorigenicity 2 (sST2), but not galactin-3, adds to prognostication in patients with systemic AL amyloidosis independent of NT-proBNP and troponin TAngela Dispenzieri, Morie A Gertz, Amy Saenger, et al.Blood Advances|December 24, 2025
Comprehensive Analysis of Subtype-Specific Outcomes and Management in Castleman Disease: A 20-Year Cohort StudyYoshito Nishimura, Thomas M Habermann, Morie A Gertz, et al.American Journal of Hematology|October 13, 2016
Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluationYi L Hwa, Qian Shi, Shaji K Kumar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2017
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for LymphomaChristopher J Gibson, R Coleman Lindsley, Vatche Tchekmedyian, et al.Blood|June 9, 2025
Eliminating the need for sequential confirmation of response in multiple myelomaJean-Sébastien Claveau, Prashant Kapoor, Moritz Binder, et al.European Journal of Haematology|February 8, 2014
Outcomes and treatments of patients with immunoglobulin light chain amyloidosis who progress or relapse postautologous stem cell transplantRahma Warsame, Soo Mee Bang, Shaji K Kumar, et al.Blood|January 12, 2012
Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogeneticsShaji Kumar, Rafael Fonseca, Rhett P Ketterling, et al.American Journal of Hematology|June 30, 2019
Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosisSurbhi Sidana, M Hasib Sidiqi, Angela Dispenzieri, et al.Pageof 61